NCT05207644View on ClinicalTrials.gov

Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' Gestation

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 9, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2022

Conditions
Pregnancy
Interventions
DRUG

30 mg letrozole followed by 800 mcg misoprostol

30 mg letrozole on day 1 followed by 800 mcg misoprostol on day 3

Trial Locations (1)

84102

Planned Parenthood Salt Lake Health Center, Salt Lake City

All Listed Sponsors
lead

Gynuity Health Projects

OTHER

NCT05207644 - Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' Gestation | Biotech Hunter | Biotech Hunter